These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2474211)
21. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3. Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282 [TBL] [Abstract][Full Text] [Related]
22. Long-term culture and characterization of alloreactive T-cell infiltrates from renal needle biopsies. Miceli C; Metzgar RS; Chedid M; Ward F; Finn OJ Hum Immunol; 1985 Nov; 14(3):295-304. PubMed ID: 2414252 [TBL] [Abstract][Full Text] [Related]
23. [Low-dose antithymocyte globulins in kidney transplantation: results of a protocol of intermittent administration]. Mourad G; Portales P; Garrigue V; Djamali A; Bouloux C; Chong G; Clot J Nephrologie; 2000; 21(5):253-8. PubMed ID: 11068775 [TBL] [Abstract][Full Text] [Related]
24. Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones. Vandekerckhove BA; Datema G; Koning F; Goulmy E; Persijn GG; Van Rood JJ; Claas FH; De Vries JE J Immunol; 1990 Feb; 144(4):1288-94. PubMed ID: 2137487 [TBL] [Abstract][Full Text] [Related]
26. Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. I. Results after combined pancreas and kidney transplantation. Cantarovich D; Le Mauff B; Hourmant M; Dantal J; Baatard R; Denis M; Jacques Y; Karam G; Paineau J; Soulillou JP Transplantation; 1994 Jan; 57(2):198-203. PubMed ID: 8310507 [TBL] [Abstract][Full Text] [Related]
27. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation. Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111 [TBL] [Abstract][Full Text] [Related]
28. Cytotoxic T Lymphocytes (CTLs) and Kidney Transplantation: An Overview. Rascio F; Pontrelli P; Grandaliano G Methods Mol Biol; 2021; 2325():203-213. PubMed ID: 34053060 [TBL] [Abstract][Full Text] [Related]
29. Alloantigen-specific cytotoxic clones bearing the alpha,beta T cell antigen receptor but not CD4 or CD8 molecules. Rivas A; Koide J; Laus R; Engleman EG J Immunol; 1990 Jul; 145(2):470-6. PubMed ID: 2142178 [TBL] [Abstract][Full Text] [Related]
30. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring. Abouna GM; al-Abdullah IH; Kelly-Sullivan D; Kumar MS; Loose J; Phillips K; Yost S; Seirka D Transplantation; 1995 Jun; 59(11):1564-8. PubMed ID: 7778170 [TBL] [Abstract][Full Text] [Related]
35. Renal allograft-infiltrating lymphocytes. A prospective analysis of in vitro growth characteristics and clinical relevance. Kirk AD; Ibrahim MA; Bollinger RR; Dawson DV; Finn OJ Transplantation; 1992 Feb; 53(2):329-38. PubMed ID: 1371194 [TBL] [Abstract][Full Text] [Related]
36. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients. Schulak JA; Mayes JT; Moritz CE; Hricik DE Transplantation; 1990 Feb; 49(2):327-32. PubMed ID: 2407003 [TBL] [Abstract][Full Text] [Related]
37. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys. Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; 't Hart BA; Boon L; Jonker M Transplantation; 2006 Nov; 82(9):1194-201. PubMed ID: 17102771 [TBL] [Abstract][Full Text] [Related]
38. Correlation of in vitro CD4+ T helper cell function with clinical graft status in immunosuppressed kidney transplant recipients. Muluk SC; Clerici M; Via CS; Weir MR; Kimmel PL; Shearer GM Transplantation; 1991 Aug; 52(2):284-91. PubMed ID: 1678559 [TBL] [Abstract][Full Text] [Related]
39. [A comparative trial of OKT3 and antilymphocyte serum in the preventive treatment of rejection after kidney transplantation in children]. Niaudet P; Murcia I; Jean G; Broyer M Ann Pediatr (Paris); 1990 Feb; 37(2):83-5. PubMed ID: 2138866 [TBL] [Abstract][Full Text] [Related]
40. Stable T-cell reactivity after successful tapering of azathioprine in HLA-identical living-related kidney transplant recipients despite minor histocompatibility antigen mismatches. Gerrits JH; van de Wetering J; Postma S; Drabbels JJ; Vaessen LM; IJzermans JN; Rischen J; Claas FH; Weimar W; van Besouw NM Nephrol Dial Transplant; 2007 Feb; 22(2):353-61. PubMed ID: 17124279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]